Quarterly 13F snapshot: US-listed longs only, no performance figures — 13F data cannot support them.
Reported portfolio value by quarter (8 quarters reported)
$231M in Q4 2021 → $60.1M now. Hover for any quarter.
As reported for the quarter ended September 30, 2023. Activity is the change in share count since the prior quarter's filing.
| Holding | % of portfolio | Activity | Shares | Value |
|---|---|---|---|---|
| Rover Group Inc | 90.0% | Unchanged | 8,638,513 | $54.1M |
| RP Recursion Pharmaceuticals In | 10.0% | Trimmed 60% | 788,762 | $6.03M |
| Angi Inc | 0.0% | Unchanged | 1,898 | $3.76K |
What changed each quarter, from the filings' own share counts. Largest moves first; most recent 7 quarters.
quarter ended September 30, 2023 · filed November 14, 2023
| Company | Action | Shares changed | Value of change | % of portfolio |
|---|---|---|---|---|
| RP Recursion Pharmaceuticals In | Trimmed | −1,183,146 | −$9.05M | 10.0% |
quarter ended June 30, 2023 · filed July 24, 2023
| Company | Action | Shares changed | Value of change | % of portfolio |
|---|---|---|---|---|
| Rover Group Inc | Trimmed | −2,879,506 | −$14.1M | 74.2% |
quarter ended March 31, 2023 · filed May 02, 2023
No position changes this quarter.
quarter ended December 31, 2022 · filed January 31, 2023
| Company | Action | Shares changed | Value of change | % of portfolio |
|---|---|---|---|---|
| P Poshmark Inc | Exited | −5,012,539 | −$78.5M | — |
quarter ended September 30, 2022 · filed November 14, 2022
No position changes this quarter.
quarter ended June 30, 2022 · filed July 28, 2022
No position changes this quarter.
quarter ended March 31, 2022 · filed May 16, 2022
No position changes this quarter.
Loading...
